Mutual exclusion of CDH1 and BRCA germline mutations in the pathway of hereditary breast cancer

Arch Gynecol Obstet. 2018 Apr;297(4):1067-1068. doi: 10.1007/s00404-018-4705-9. Epub 2018 Feb 3.

Authors

G Corso¹, B Bonanni², P Veronesi^{3

4}, V Galimberti³

Affiliations

¹ Division of Breast Cancer Surgery, European Institute of Oncology, Via G. Ripamonti 435, 20141, Milan, Italy. giovanni.corso@ieo.it.
² Division of Cancer Prevention and Genetics, European Institute of Oncology, Via G. Ripamonti 435, 20141, Milan, Italy.
³ Division of Breast Cancer Surgery, European Institute of Oncology, Via G. Ripamonti 435, 20141, Milan, Italy.
⁴ Faculty of Medicine, University of Milan, Milan, Italy.

PMID: 29397440
DOI: 10.1007/s00404-018-4705-9

No abstract available

Publication types

Letter
Comment

MeSH terms

Antigens, CD
Breast Neoplasms
Cadherins / genetics*
Cohort Studies
Germ-Line Mutation*
Humans
Ovarian Neoplasms

Substances

Antigens, CD
CDH1 protein, human
Cadherins